Annalisa Ariano
Overview
Explore the profile of Annalisa Ariano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amato L, Omodei D, De Rosa C, Ariano A, Capaldo S, Tufano C, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682133
Background: Oncogene-driven NSCLC is usually treated with targeted therapies using tyrosine kinase inhibitors (TKIs) to inhibit oncogene downstream signaling pathways, affecting tumor survival and proliferation. EGFR- and KRAS-mutant NSCLCs are...
2.
Amato L, De Rosa C, De Rosa V, Heydari Sheikhhossein H, Ariano A, Franco P, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335123
Small cell lung cancer (SCLC) is a highly invasive and rapidly proliferating lung tumor subtype. Most patients respond well to a combination of platinum-based chemotherapy and PD-1/PDL-1 inhibitors. Unfortunately, not...
3.
De Rosa C, Iommelli F, De Rosa V, Ercolano G, Sodano F, Tuccillo C, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672164
Background: Lung cancer (LC), including both non-small (NSCLC) and small (SCLC) subtypes, is currently treated with a combination of chemo- and immunotherapy. However, predictive biomarkers to identify high-risk patients are...